Invesco Biotechnology & Genome ETF (NYSEARCA:PBE – Get Free Report) was the recipient of a large decrease in short interest during the month of January. Invesco Biotechnology & Genome ETF Stock PerformanceShares of PBE stock traded down $0.89 during midday trading on Wednesday, reaching $82.36. Get Invesco Biotechnology & Genome ETF alerts:Institutional Investors Weigh In On Invesco Biotechnology & Genome ETFA number of institutional investors and hedge funds have recently modified their holdings of the stock. Invesco Biotechnology & Genome ETF Company ProfilePowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). Featured ArticlesReceive News & Ratings for Invesco Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.